Outcomes of Patients With Small and Node-Negative HER2+ Early Breast Cancer Receiving Adjuvant Chemotherapy and Anti-HER2 Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study
Br. J. Cancer 2022 Sep 01;[EPub Ahead of Print], G Nader-Marta, V Debien, D Eiger, Z Tsourti, R Caparica, M Kassapian, S Napoleone, S Hultsch, L Korde, Y Wang, S Chumsri, KI Pritchard, M Untch, M Bellet-Ezquerra, D Dornelles Rosa, A Moreno-Aspitia, M Piccart, U Dafni, E de AzambujaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.